EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy. - sprookjes - yvandenbroek - TriplyDB

EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.

EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.

http://www.wikidata.org/entity/Q36223297

about

Role of Receptor Tyrosine Kinase Signaling in Renal Fibrosis Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats.Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis COX-2/mPGES-1/PGE2 cascade activation mediates uric acid-induced mesangial cell proliferation.Baicalein decreases uric acid and prevents hyperuricemic nephropathy in mice.The epidermal growth factor receptor pathway in chronic kidney diseases.Blocking fibrotic signaling in fibroblasts from patients with carpal tunnel syndrome.Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters.Recent advances on uric acid transporters.Genetic or pharmacologic inhibition of EGFR ameliorates sepsis-induced AKI.Deletion of the EGF receptor in vascular smooth muscle cells prevents chronic angiotensin II-induced arterial wall stiffening and media thickening.High Uric Acid-Induced Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells via the TLR4/NF-kB Signaling Pathway.Febuxostat attenuates ER stress mediated kidney injury in a rat model of hyperuricemic nephropathy.

P2860

Q26743407-1EF23FD4-AD8D-4A7B-882B-EDF7CA66B148 Q33779697-05EE67F6-2C34-451E-8A3F-1BFDFECA72FC Q33868118-602F2C77-76BB-4BD1-BB10-6A0883AA0AC5 Q37688355-69B67107-502E-421C-BCA4-6FEE7F647B67 Q37705805-9BD6ADA0-14D6-4868-B379-F6138F98E227 Q38818748-9A8E7325-7E60-4863-BB1C-B47C217E844C Q38885079-591C4453-4FD5-44DD-A446-949DBDBB22C4 Q39179076-C175F407-019D-4C97-8793-546AE83570A9 Q41878918-E08FAFF8-6978-47D8-9FB0-DD94D087B113 Q47131336-9FB74BD6-7F93-4362-B62C-1D819AC5CEC6 Q47137909-CEA00555-6A4E-4095-925F-A562515C3458 Q47448214-F862AADD-4FFA-458D-97F0-8952BC91A3DD Q47826501-3B50248D-C516-4107-8F7B-6226F3E9E22A Q49471112-BBFE3326-3F54-4777-A07A-C3E9BF3C630E

P2860

EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.

http://www.wikidata.org/entity/Q36223297

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.

@ast

EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.

@en

type

label

EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.

@ast

EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.

@en

prefLabel

EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.

@ast

EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.

@en

P1433

Q36223297-18675309-DDFB-4151-9D68-8CE26C064523

P1476

Q36223297-A2A64D4B-5616-4FBB-A23C-9AEBDE3879A2

P2093

Q36223297-2081554A-C01C-459A-9B0E-0A85C24624B6

Q36223297-35CFC274-A937-4AC8-B9CE-9941564A800F

Q36223297-46892201-4AB1-456D-9EBD-5B1ADAB45321

Q36223297-484D6CAC-56AD-41BE-B2A9-6C571DD9C4F5

Q36223297-9805A307-6C77-44B7-93EC-008C7D753C6B

Q36223297-98644FAD-B0E0-4664-AD94-FEFF2BF71692

Q36223297-B7FEF855-D8EA-43E0-A4B8-00FB84081AA3

Q36223297-CC74F2E1-32D6-4461-B3F2-5E3A7F0D1A03

Q36223297-DFA8A29F-2ECA-4954-A4E5-32E4758268A1

Q36223297-F5F7D2C1-85AD-4104-A3A7-CF77D036EFBD

P2860

Q36223297-00DB3102-7EE4-4206-AF7F-B62D346077CC

Q36223297-03410F4B-EAF8-4689-B0B5-416328033E17

Q36223297-04CE9522-3266-4FEC-AF13-A4F45A8C7537

Q36223297-059EB4B6-F686-4262-8698-4074B26487FE

Q36223297-084FDAB8-D57E-4A2F-A681-AD6F07973469

Q36223297-0BADD0F3-0EAA-4486-AB8C-27687029FF12

Q36223297-0F73EC6E-7C91-4704-84B3-8A9675CB3DB9

Q36223297-1B5B6D81-3B15-4877-B966-6A5561CEAC42

Q36223297-2205EBA3-E463-42DC-B905-798527DD4F63

Q36223297-22D70460-C0A7-4D3B-8A93-87443A99294B

P304

Q36223297-362FC395-98B4-4C54-87B1-F32B2AF17C5A

P31

Q36223297-64C97853-1373-4982-A8D4-040A18FB0FD8

P356

Q36223297-E07B265A-FAC5-4567-A38F-3BB5B3D988FF

P433

Q36223297-A97F0C40-899D-4C51-A3EE-80717DA4B34B

P478

Q36223297-477A7C89-02DB-4DDC-94DC-3A12C86B1E3B

P577

Q36223297-9F7E63D5-AFE2-4387-9911-CD5A58D81023

P698

Q36223297-33AA4A22-F850-4FE2-9738-E5DF0FE2597E

P932

Q36223297-6E83DD4B-9E6D-4C33-BA94-5BE862EF491F

P356

P1433

Journal of the American Society of Nephrology

P1476

EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy.

@en

P2093

Andong Qiu

http://www.w3.org/2001/XMLSchema#string

Chongxiang Xiong

http://www.w3.org/2001/XMLSchema#string

Haidong Yan

http://www.w3.org/2001/XMLSchema#string

Li Wang

http://www.w3.org/2001/XMLSchema#string

Liuqing Xu

http://www.w3.org/2001/XMLSchema#string

Na Liu

http://www.w3.org/2001/XMLSchema#string

Shi-Bin Cheng

http://www.w3.org/2001/XMLSchema#string

Shougang Zhuang

http://www.w3.org/2001/XMLSchema#string

Tao Yang

http://www.w3.org/2001/XMLSchema#string

Wenfang Bao

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular physiology of urate transport

Uric acid and chronic kidney disease: which is chasing which?

Uric acid, hyperuricemia and vascular diseases

Evolutionary history and metabolic insights of ancient mammalian uricases

Suramin alleviates glomerular injury and inflammation in the remnant kidney

Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction

p-aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPT1.

Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study.

Evolution of urate-degrading enzymes in animal peroxisomes.

Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

P304

2716-2729

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2014080793

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25788532

http://www.w3.org/2001/XMLSchema#string

P932

4625671

http://www.w3.org/2001/XMLSchema#string